Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pre-treatment comorbidities, C-reactive protein and eosinophil count, and immune-related adverse events as predictors of survival with checkpoint inhibition for multiple tumour entities.
Mehra T, Dongre K, Boesing M, Frei P, Suenderhauf C, Zippelius A, Leuppi JD, Wicki A, Leuppi-Taegtmeyer AB. Mehra T, et al. Among authors: leuppi taegtmeyer ab. Cancer Med. 2023 Jun;12(11):12253-12262. doi: 10.1002/cam4.5919. Epub 2023 Apr 21. Cancer Med. 2023. PMID: 37084178 Free PMC article.
Prediction of Acute COPD Exacerbation in the Swiss Multicenter COPD Cohort Study (TOPDOCS) by Clinical Parameters, Medication Use, and Immunological Biomarkers.
Huebner ST, Henny S, Giezendanner S, Brack T, Brutsche M, Chhajed P, Clarenbach C, Dieterle T, Egli A, Frey M, Heijnen I, Irani S, Sievi NA, Thurnheer R, Trendelenburg M, Kohler M, Leuppi-Taegtmeyer AB, Leuppi JD. Huebner ST, et al. Respiration. 2022;101(5):441-454. doi: 10.1159/000520196. Epub 2021 Dec 23. Respiration. 2022. PMID: 34942619 Free PMC article.
High-dose vitamin D substitution in patients with COVID-19: study protocol for a randomized, double-blind, placebo-controlled, multi-center study-VitCov Trial.
Jaun F, Boesing M, Lüthi-Corridori G, Abig K, Makhdoomi A, Bloch N, Lins C, Raess A, Grillmayr V, Haas P, Schuetz P, Gabutti L, Muser J, Leuppi-Taegtmeyer AB, Giezendanner S, Brändle M, Leuppi JD. Jaun F, et al. Trials. 2022 Feb 4;23(1):114. doi: 10.1186/s13063-022-06016-2. Trials. 2022. PMID: 35120577 Free PMC article.
Disease-Drug Interactions Requiring Special Attention.
Dongre K, Jungo A, Späni S, Zysset Y, Leuppi-Taegtmeyer A. Dongre K, et al. Praxis (Bern 1994). 2022 Sep;111(12):700-705. doi: 10.1024/1661-8157/a003923. Praxis (Bern 1994). 2022. PMID: 36102026
Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: study protocol for a randomized, placebo-controlled, and multicenter trial.
Boesing M, Abig K, Brändle M, Brutsche M, Burri E, Frye BC, Giezendanner S, Grutters JC, Haas P, Heisler J, Jaun F, Leuppi-Taegtmeyer AB, Lüthi-Corridori G, Müller-Quernheim J, Nüesch R, Pohl W, Rassouli F, Leuppi JD. Boesing M, et al. Trials. 2022 Sep 20;23(1):790. doi: 10.1186/s13063-022-06723-w. Trials. 2022. PMID: 36127739 Free PMC article.
[Predictors for Early Unplanned Readmissions].
Rageth L, Leuppi JD, Leuppi-Taegtmeyer AB, Lüthi-Corridori G, Boesing M. Rageth L, et al. Praxis (Bern 1994). 2023 Feb;112(2):75-81. doi: 10.1024/1661-8157/a003992. Praxis (Bern 1994). 2023. PMID: 36722109 Free article. German.
48 results